Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-21-002300)

Filing Details

Accession Number:: 0001562180-21-002300
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-17 17:13:20
Reporting Period:: 2021-03-17

Accepted Time:: 2021-03-17 17:13:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1689813	Biohaven Pharmaceutical Holding Co Ltd.	BHVN	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1027035	W John Childs	C/O Biohaven Pharmaceuticals, Inc. 215 Church Street New Haven CT 06510		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2021-03-17	13,157	$76.00	2,545,801	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	10,000	Indirect	By John W Childs 2013 Revocable Trust